GENDELL JEFFREY L - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
GENDELL JEFFREY L ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$57,838,105
-35.0%
5,615,350
+4.1%
3.29%
-52.3%
Q2 2023$88,927,069
+83.1%
5,396,060
+1.8%
6.90%
+51.7%
Q1 2023$48,565,532
+32.5%
5,301,914
+3.5%
4.55%
+40.0%
Q4 2022$36,663,532
+52.9%
5,120,605
+7.0%
3.25%
+3.3%
Q3 2022$23,979,000
+130.8%
4,786,327
+12.4%
3.14%
+161.8%
Q2 2022$10,391,000
-46.4%
4,258,696
+50.1%
1.20%
-13.7%
Q1 2022$19,380,000
-2.0%
2,837,431
+16.0%
1.39%
-13.3%
Q4 2021$19,766,000
-2.0%
2,446,299
+18.8%
1.60%
-7.4%
Q3 2021$20,176,000
+47.2%
2,058,770
+1.1%
1.73%
+42.7%
Q2 2021$13,703,000
-21.6%
2,036,114
+5.3%
1.21%
-34.9%
Q1 2021$17,482,000
+55.7%
1,933,837
+15.0%
1.86%
+22.9%
Q4 2020$11,231,000
+99.8%
1,681,391
+50.8%
1.52%
+28.2%
Q3 2020$5,621,000
-33.2%
1,115,211
+7.0%
1.18%
-44.9%
Q2 2020$8,418,000
+91.5%
1,041,838
+88.2%
2.15%
+59.4%
Q1 2020$4,395,000
-49.2%
553,516
-51.7%
1.35%
+21.0%
Q4 2019$8,658,000
+462.9%
1,146,764
+210.2%
1.11%
+407.8%
Q3 2019$1,538,000369,7260.22%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders